• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS VASCULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS VASCULAR STENT GRAFT Back to Search Results
Catalog Number FVL06080
Device Problems Positioning Failure (1158); Fracture (1260)
Patient Problem Hematoma (1884)
Event Date 08/21/2017
Event Type  Injury  
Manufacturer Narrative
No medical records or no medical images have been made available to the manufacturer.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that during a stent graft deployment procedure to treat a hematoma in the proximal end of the left superficial femoral artery by contralateral access through the right common femoral artery, the stent graft was allegedly unable to deploy.Reportedly, the tracking vessels were calcified and the iliac arteries were tortuous, however a stiff wire was used to avoid issues with advancing the stent graft into the target lesion.It was further reported that during stent graft deployment, resistance was felt which prompted the health care provider to forcibly attempt to deploy and resulted in the shaft to break.Furthermore, the prolonged procedure resulted in a larger hematoma than as it was originally, therefore medical intervention was required to treat the hematoma.Another device was used to complete the procedure.Current patient status unknown.
 
Manufacturer Narrative
Manufacturing review: the lot records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.The review shows that no remarkable incidents occurred during the manufacturing process.No relevant manufacturing process changes were implemented, that could have led to the event reported.No additional complaint has been reported for this lot number previously.Investigation summary: on the basis of the returned stent graft delivery system, the alleged deployment failure could be confirmed.The outer sheath was found to be elongated, which indicated that a high deployment force was present during the deployment attempt, which subsequently resulted in an outer catheter fracture.Based on the information available and the evaluation of the sample returned, a definite root cause for the reported event could not be determined.Labeling review: in reviewing the labeling supplied with this product it was found that the instructions for use (ifu) sufficiently address the potential risks.Regarding preparation of the device the ifu states that "prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline (.).Flushing these lumens will also facilitate stent graft deployment." regarding the anatomy of the placement site the ifu states: "prior to stent graft deployment (.), ensure that the proximal stent graft end is positioned in a straight section of the lumen to reduce the risk of increased deployment forces and possible failure to deploy." (b)(4).
 
Event Description
It was reported that during a stent graft deployment procedure to treat a hematoma in the left proximal sfa by contralateral access through the right common femoral artery, the stent graft was allegedly unable to deploy.Reportedly, during stent graft deployment, resistance was felt which prompted the health care provider to forcibly attempt to deploy and resulted in the shaft to break.Furthermore, the prolonged procedure resulted in a larger hematoma than as it was originally, therefore medical intervention was required to treat the hematoma.Another device was used to complete the procedure.Current patient status unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS VASCULAR STENT GRAFT
Type of Device
VASCULAR STENT GRAFT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM   76227
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key6901884
MDR Text Key87723538
Report Number9681442-2017-00274
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodePL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 11/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2020
Device Catalogue NumberFVL06080
Device Lot NumberANBR1722
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/04/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/04/2017
Initial Date FDA Received09/28/2017
Supplement Dates Manufacturer Received10/26/2017
Supplement Dates FDA Received11/10/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/29/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient Weight67
-
-